Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy

Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression ‐free survival without the adverse effects of steroid‐based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor. AbstractCurcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression ‐free survival without the adverse effects of steroid‐based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor.

Source: Clinical Case Reports - February 28, 2020 Category: General Medicine Authors: Rajeev Ramakrishna, Terrence H. Diamond, William Alexander, Arumugam Manoharan, Terry Golombick Tags: CASE REPORT Source Type: research